Xspray Pharma AB (publ) (STO: XSPRAY)
Sweden
· Delayed Price · Currency is SEK
42.40
-1.00 (-2.30%)
Nov 18, 2024, 11:29 AM CET
Xspray Pharma AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
Cash & Equivalents | 74.76 | 166.3 | 120.17 | 271.88 | 325.6 | 209.87 | Upgrade
|
Cash & Short-Term Investments | 74.76 | 166.3 | 120.17 | 271.88 | 325.6 | 209.87 | Upgrade
|
Cash Growth | -43.57% | 38.39% | -55.80% | -16.50% | 55.14% | -5.15% | Upgrade
|
Other Receivables | 3.5 | 4.17 | 2.59 | 2.5 | 3.32 | 5.71 | Upgrade
|
Receivables | 3.5 | 4.17 | 2.59 | 2.5 | 3.32 | 5.71 | Upgrade
|
Inventory | 20.71 | 43.78 | 8.55 | 6.2 | - | - | Upgrade
|
Prepaid Expenses | 2.53 | 3.57 | 0.93 | 1.48 | 2.1 | 0.55 | Upgrade
|
Other Current Assets | - | - | -0 | -0 | - | - | Upgrade
|
Total Current Assets | 101.5 | 217.82 | 132.23 | 282.07 | 331.02 | 216.13 | Upgrade
|
Property, Plant & Equipment | 104.4 | 107.65 | 64.6 | 44.6 | 42.67 | 43.03 | Upgrade
|
Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Long-Term Deferred Charges | 458.67 | 436.78 | 385.6 | 296.24 | 231.62 | 141.52 | Upgrade
|
Other Long-Term Assets | 3.13 | 3.02 | 3 | - | - | 0 | Upgrade
|
Total Assets | 667.7 | 765.26 | 585.43 | 622.9 | 605.3 | 400.67 | Upgrade
|
Accounts Payable | 19.23 | 12.47 | 14.79 | 16.87 | 8.44 | 11.88 | Upgrade
|
Accrued Expenses | 16.59 | 16.31 | 11.41 | 10.3 | 8.54 | 7.52 | Upgrade
|
Current Portion of Leases | 5.05 | 4.86 | 1.57 | 2.05 | 1.99 | 0.88 | Upgrade
|
Other Current Liabilities | 12.68 | 6.26 | 1.09 | 0.75 | 0.86 | 2.23 | Upgrade
|
Total Current Liabilities | 53.54 | 39.9 | 28.85 | 29.97 | 19.82 | 22.5 | Upgrade
|
Long-Term Leases | 28.56 | 31.95 | 0.56 | 1.19 | 2.9 | 4.45 | Upgrade
|
Total Liabilities | 82.1 | 71.85 | 29.41 | 31.15 | 22.72 | 26.96 | Upgrade
|
Common Stock | 33.76 | 31.25 | 22.68 | 20.68 | 18.89 | 16.75 | Upgrade
|
Additional Paid-In Capital | 1,309 | 1,216 | 907.42 | 813.48 | 709.41 | 450.27 | Upgrade
|
Retained Earnings | -757.49 | -553.93 | -374.08 | -242.41 | -145.71 | -93.3 | Upgrade
|
Comprehensive Income & Other | 0 | -0 | - | - | - | - | Upgrade
|
Shareholders' Equity | 585.59 | 693.41 | 556.02 | 591.75 | 582.59 | 373.72 | Upgrade
|
Total Liabilities & Equity | 667.7 | 765.26 | 585.43 | 622.9 | 605.3 | 400.67 | Upgrade
|
Total Debt | 33.61 | 36.81 | 2.13 | 3.23 | 4.88 | 5.33 | Upgrade
|
Net Cash (Debt) | 41.15 | 129.5 | 118.04 | 268.65 | 320.72 | 204.54 | Upgrade
|
Net Cash Growth | -68.78% | 9.70% | -56.06% | -16.23% | 56.80% | -7.56% | Upgrade
|
Net Cash Per Share | 1.26 | 4.87 | 5.60 | 13.96 | 18.63 | 13.44 | Upgrade
|
Filing Date Shares Outstanding | 33.76 | 31.25 | 22.68 | 20.68 | 18.89 | 16.75 | Upgrade
|
Total Common Shares Outstanding | 33.76 | 31.25 | 22.68 | 20.68 | 18.89 | 16.75 | Upgrade
|
Working Capital | 47.96 | 177.91 | 103.38 | 252.1 | 311.2 | 193.62 | Upgrade
|
Book Value Per Share | 17.34 | 22.19 | 24.52 | 28.61 | 30.84 | 22.31 | Upgrade
|
Tangible Book Value | 585.59 | 693.41 | 556.02 | 591.75 | 582.59 | 373.72 | Upgrade
|
Tangible Book Value Per Share | 17.34 | 22.19 | 24.52 | 28.61 | 30.84 | 22.31 | Upgrade
|
Machinery | - | 50.03 | 49.82 | 46.96 | 39.87 | 39.18 | Upgrade
|
Construction In Progress | - | 59.37 | 46.57 | 20.04 | 15.75 | 8.47 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.